These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1405170)

  • 1. [Prophylactic intravesical instillation therapy in patients with superficial bladder cancer--results of a randomized prospective study].
    Tsushima T; Nasu Y; Abeki N; Noda M; Saika T; Ohmori H; Kobashi K; Ozaki Y; Matsumura Y; Tanahashi T
    Nihon Hinyokika Gakkai Zasshi; 1992 Aug; 83(8):1314-21. PubMed ID: 1405170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic intravesical instillation therapy with adriamycin and mitomycin C in patients with superficial bladder cancer.
    Tsushima T; Matsumura Y; Ozaki Y; Yoshimoto J; Ohmori H
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S72-6. PubMed ID: 3117400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [5 years intravesical instillation with mitomycin-C and pirarubicin as a prophylactic treatment for superficial bladder cancer].
    Kobayashi S; Oka K; Machida T; Ishizaka K
    Nihon Hinyokika Gakkai Zasshi; 2006 May; 97(4):636-41. PubMed ID: 16768144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 4th study of prophylactic intravesical chemotherapy with adriamycin in the treatment of superficial bladder cancer: the experience of the Japanese Urological Cancer Research Group for Adriamycin.
    Matsumura Y; Akaza H; Isaka S; Kagawa S; Koiso K; Kotake T; Machida T; Niijima T; Obata K; Ohashi Y
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S10-4. PubMed ID: 1394809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of the preoperative intravesical instillation of doxorubicin and the oral administration of 5-fluorouracil in preventing recurrence after a transurethral resection of superficial bladder cancer. Kyushu University Urological Oncology Group.
    Naito S; Iguchi A; Sagiyama K; Ariyoshi A; Osada Y; Omoto T; Kuriya N; Kumazawa J
    Int J Urol; 1997 Jul; 4(4):352-7. PubMed ID: 9256323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic intravesical instillation chemotherapy against recurrence after a transurethral resection of superficial bladder cancer: a randomized controlled trial of doxorubicin plus verapamil versus doxorubicin alone. The Kyushu University Urological Oncology Group.
    Naito S; Kotoh S; Omoto T; Osada Y; Sagiyama K; Iguchi A; Ariyoshi A; Hiratsuka Y; Kumazawa J
    Cancer Chemother Pharmacol; 1998; 42(5):367-72. PubMed ID: 9771950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: prospective randomised FinnBladder-4 study.
    Järvinen R; Marttila T; Kaasinen E; Rintala E; Aaltomaa S; Kallio J; Liukkonen T; Puolakka VM; Seppänen M; Tuhkanen K; Vaarala M; Viitanen J; Boström PJ;
    Eur Urol; 2015 Oct; 68(4):611-7. PubMed ID: 25748117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic chemotherapy for primary and recurrent superficial bladder cancer: preliminary results. The Hokkaido University Bladder Cancer Collaborating Group.
    Togashi M; Shinohara N; Toyota K; Koyanagi T; Maru A; Fujieda J; Kawakura K; Nishida T; Ohashi N
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S21-5. PubMed ID: 1394811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study.
    Martinez-Pineiro JA; Jimenez León J; Martinez-Pineiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
    Prog Clin Biol Res; 1989; 310():237-52. PubMed ID: 2505269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy with early intravesical instillation of adriamycin and long-term oral administration of 5-fluorouracil in superficial bladder cancer. The Kyushu University Urological Oncology Group.
    Ueda T; Naito S; Iguchi A; Sagiyama K; Osada Y; Ariyoshi A; Omoto T; Kumazawa J
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S31-6. PubMed ID: 1394813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early intravesical instillation of adriamycin with oral administration of 5-fluorouracil after transurethral resection for superficial bladder cancer: preliminary results.
    Ueda T; Iguchi A; Sagiyama K; Osada Y; Ariyoshi A; Omoto T; Kumazawa J
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S81-4. PubMed ID: 3664948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer. Prospective, randomized, controlled studies of the Japanese Urological Cancer Research Group.
    Akaza H; Isaka S; Koiso K; Kotake T; Machida T; Maru A; Matsumura Y; Niijima T; Obata K; Ohe H
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S91-6. PubMed ID: 3117403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravesical instillation chemotherapy of anticancer agents including cylocide: studies of prophylactic effects on the recurrence].
    Yasumoto R; Asakawa M; Yoshihara H; Sakamoto W; Iseki T; Nakatani T; Wada S; Kishimoto T; Maekawa M; Nishio S
    Hinyokika Kiyo; 1990 Apr; 36(4):407-13. PubMed ID: 2116082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of a randomized, double blind prospective study of intravesical chemoprophylaxis with 2 drugs: adriamycin and mitomycin; and 2 ways of initiating the instillations: early and late. Effect on recurrence and progression].
    Iborra Juan I; Ricos Torrent JV; Monrós Lliso JL; Dumont Martínez R; Casanova Ramón-Borja J; Solsona Narbón E
    Arch Esp Urol; 1992 Dec; 45(10):1001-7. PubMed ID: 1294028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravesical therapy with adriamycin plus verapamil in patients with superficial bladder cancer: a pilot study.
    Naito S; Kimiya K; Ueda T; Kumazawa J; Omoto T; Osada Y; Iguchi A; Ariyoshi A; Sagiyama K
    Urol Int; 1992; 48(3):270-3. PubMed ID: 1589915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of intravesical chemoprophylaxis of superficial bladder cancer: experience of the Japanese Urological Cancer Research Group for Adriamycin.
    Akaza H; Koiso K; Kotake T; Matsumura Y; Isaka S; Machida T; Obata K; Ohashi Y; Ohe H; Ohi Y
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S15-20. PubMed ID: 1394810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of cytostatic intravesical instillation in patients with superficial bladder carcinoma. Is short-term, intensive instillation better than maintenance therapy?
    Schwaibold H; Pichlmeier U; Klingenberger HJ; Huland H
    Eur Urol; 1997; 31(2):153-9. PubMed ID: 9076457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of superficial bladder carcinoma after intravesical instillation of mitomycin-C. Comparison of exposure times.
    Giesbers AA; Van Helsdingen PJ; Kramer AE
    Br J Urol; 1989 Feb; 63(2):176-9. PubMed ID: 2495144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of intravesical instillation therapy of superficial bladder tumor--combination therapy of mitomycin C, adriamycin, peplomycin and cytosine arabinoside].
    Kinoshita N; Tochigi H; Yanagawa M; Yamakawa K; Sakurai M; Hioki T; Kawamura J
    Hinyokika Kiyo; 1990 Mar; 36(3):257-63. PubMed ID: 1693807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
    Divrik RT; Yildirim U; Zorlu F; Ozen H
    J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.